The pharmacy sector seems to have mellowed when it comes to the King Review
It’s fair to say that from the outset, there was a certain amount of trepidation in pharmacy over the Review of Pharmacy Remuneration and Regulation. As far back as April 2016 – when the Review was expected to release its initial discussion paper – AJP readers were expressing concern.
In a poll at the time, we asked how confident readers were that the Review would benefit pharmacy, and over 80% said they at least had some concerns, with 32% of total readers labelling the King Review “a potential disaster”.
And at APP 2017, the audience at one session were asked what they thought of the Review – which by then was very tardy – and around 50% said it should be “binned”. Nobody said it was “good overall”.
So what’s changed? Now that the Interim Paper has been released, more AJP readers seem to approve of the Review than disapprove.
In our poll, 12% of respondents labelled the Review “excellent” and 28% said it had more good points than bad points, adding up to 40% generally feeling positive at the time of writing.
Fourteen per cent said it was “terrible” and 17% said it had more bad points than good, adding up to 31%. A further 8% said it was “neither good nor bad” while 9% said they were indifferent.
And a very honest 12% said they hadn’t actually read the report, which runs to over 220 pages.